What each one is for, how to take it, side effects and warnings, side by side from the official labels.
| Lamivudine | Dolutegravir | |
|---|---|---|
| What it is | An antiviral | An antiviral |
| Used for | Lamivudine is nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Limitations of Use: • The dosage of this product is for HIV-1 and not for HBV. Lamivudine is… | and TRIUMEQ PD are indicated for the treatment of HIV-1 infection in adults and in pediatric patients aged at least 3 months and weighing at least 6 kg. Limitations of Use: TRIUMEQ and TRIUMEQ PD alone are not recommended in patients with resistance‑associated… |
| Usual adult dose | Adults: 300 mg daily, administered as either 150 mg twice daily or 300 mg once daily. | Adults: One tablet of TRIUMEQ daily. |
| Children | Pediatric Patients Aged 3 Months and Older: Administered either once or twice daily. | Pediatric Population Body Weight Number of Tablets (once daily) Recommended Daily Dose TRIUMEQ PD Tablets (6 kg to. |
| Prescription (U.S.) | Yes | Yes |
| Common side effects | The following adverse reactions are discussed in other sections of the labeling: • Exacerbations of hepatitis B [see Boxed Warning, Warnings and Precautions ( 5.1 )]. • Lactic acidosis and severe hepatomegaly with steatosis [see W… | The following adverse reactions are discussed in other sections of the labeling: • Serious and sometimes fatal hypersensitivity reaction [see Boxed Warning , Warnings and Precautions ( 5.1 )] . • Exacerbations of hepatitis B [see… |
| Serious warning | B, and DIFFERENT FORMULATIONS OF LAMIVUDINE Exacerbations of Hepatitis B Severe acute exacerbations of hepatitis B have been reported in patients who are co-infected with hepatitis B virus (HBV) and h… | REACTIONS, AND EXACERBATIONS OF HEPATITIS B Hypersensitivity Reactions Serious and sometimes fatal hypersensitivity reactions, with multiple organ involvement, have occurred with abacavir, a component… |
| Pregnancy | 8.1 Pregnancy Pregnancy Exposure Registry There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to lamivudine during pregnancy. Healthcare providers are encouraged t… | 8.1 Pregnancy Pregnancy Exposure Registry There is a pregnancy exposure registry that monitors pregnancy outcomes in individuals exposed to TRIUMEQ during pregnancy. Healthcare providers are encourage… |
From the official U.S. labels. Brands and strengths differ between countries.
The official labels mention them together: With prior hypersensitivity reaction to abacavir, dolutegravir [see warnings and precautions ] , or lamivudine. Ask a pharmacist before combining them.
Check them togetherLamivudine is an antiviral and Dolutegravir is an antiviral. Lamivudine is used for: Lamivudine is nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Limitations of Use: • The dosage of this product is for HIV-1 and not for HBV. Lamivudine is… Dolutegravir is used for: and TRIUMEQ PD are indicated for the treatment of HIV-1 infection in adults and in pediatric patients aged at least 3 months and weighing at least 6 kg. Limitations of Use: TRIUMEQ and TRIUMEQ PD alone are not recommended in patients with resistance‑associated…
The official labels mention them together: With prior hypersensitivity reaction to abacavir, dolutegravir [see warnings and precautions ] , or lamivudine. Ask a pharmacist before combining them.
It depends on what you are treating, your health and other medicines. Your doctor or pharmacist can tell you which one suits you; this page shows what each official label says.